Characterization of binding of the ATP-sensitive potassium channel ligand, [3H]glyburide, to neuronal and muscle preparations

M Gopalakrishnan, DE Johnson, RA Janis and DJ Triggle

Department of Biochemical Pharmacology, School of Pharmacy, State University of New York, Buffalo.

Binding of the hypoglycemic sulfonylurea, [3H]glyburide, to crude membrane fractions from brain, heart and smooth (intestinal) muscle was saturable, linear with protein concentration and reversible. Saturation analysis revealed high affinity sites (KH values, 7 x 10(-11) M, 5 x 10(-11) M and 6 x 10(-11) M), with Bmax-H values 209, 36 and 23 fmol/mg protein in the brain, heart and smooth muscle, respectively. High affinity [3H]glyburide binding was pharmacologically specific, insensitive to a variety of receptor-active ligands, but sensitive to a series of sulfonylureas, and good, essentially 1:1, correlations were obtained between binding affinities and literature-derived pharmacologic activities. The K+ channel activators, cromakalim, nicorandil, pinacidil and minoxidil were not effective as inhibitors of [3H]glyburide binding. However, diazoxide was a modestly effective inhibitor. Putative low affinity sites (KL values, 3 x 10(-7) M, 1 x 10(-7) M and 2 x 10(-9) M) with Bmax-L values 4956, 336 and 53 fmol/mg protein in brain, heart and smooth muscle, respectively, were identified. Their significance remains to be established. Except for ATP gamma S, the ability of nucleotide triphosphates to inhibit high affinity [3H] glyburide binding was dependent on the presence of Mg++. ADP, in the presence of Mg++, inhibited binding with an IC50 value of 6.3 x 10(-4) M. Nucleotide monophosphates did not inhibit [3H] glyburide binding in the presence or absence of Mg++, whereas in the presence of Mg++, nucleotide triphosphates were equally potent inhibitors of binding. The rank order potency for nucleotide diphosphate inhibition of binding, in the presence of Mg++, is ADP greater than GDP greater than IDP = UDP. In the absence of Mg++, [3H]glyburide binding shows a biphasic response to ADP, and the inhibition of binding by ADP was prevented by ATP. It is suggested that this biphasic response is the result of a second nucleotide binding site.

Volume 257, Issue 3, pp. 1162-1171, 06/01/1991
Copyright © 1991 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				H. Heissig, K. A. Urban, K. Hastedt, B. J. Zunkler, and U. Panten Mechanism of the Insulin-Releasing Action of {alpha}-Ketoisocaproate and Related {alpha}-Keto Acid Anions Mol. Pharmacol., October 1, 2005; 68(4): 1097 - 1105. [Abstract] [Full Text] [PDF]

				R. Davis-Taber, E. J. Molinari, R. J. Altenbach, K. L. Whiteaker, C.-C. Shieh, G. Rotert, S. A. Buckner, J. Malysz, I. Milicic, J. S. McDermott, et al. [125I]A-312110, a Novel High-Affinity 1,4-Dihydropyridine ATP-sensitive K+ Channel Opener: Characterization and Pharmacology of Binding Mol. Pharmacol., July 1, 2003; 64(1): 143 - 153. [Abstract] [Full Text] [PDF]

				R. Lingamaneni and H. C. Hemmings Jr Differential interaction of anaesthetics and antiepileptic drugs with neuronal Na+ channels, Ca2+ channels, and GABAA receptors Br. J. Anaesth., February 1, 2003; 90(2): 199 - 211. [Abstract] [Full Text] [PDF]

				M. Gopalakrishnan, S. A. Buckner, K. L. Whiteaker, C.-C. Shieh, E. J. Molinari, I. Milicic, A. V. Daza, R. Davis-Taber, V. E. Scott, D. Sellers, et al. (-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-Dioxide (A-278637): A Novel ATP-Sensitive Potassium Channel Opener Efficacious in Suppressing Urinary Bladder Contractions. I. In Vitro Characterization J. Pharmacol. Exp. Ther., October 1, 2002; 303(1): 379 - 386. [Abstract] [Full Text] [PDF]

				L. Aguilar-Bryan and J. Bryan Molecular Biology of Adenosine Triphosphate-Sensitive Potassium Channels Endocr. Rev., April 1, 1999; 20(2): 101 - 135. [Abstract] [Full Text]

				M. Gopalakrishnan, K. L. Whiteaker, E. J. Molinari, R. Davis-Taber, V. E. S. Scott, C.-C. Shieh, S. A. Buckner, I. Milicic, J. C. Cain, S. Postl, et al. Characterization of the ATP-Sensitive Potassium Channels (KATP) Expressed in Guinea Pig Bladder Smooth Muscle Cells J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 551 - 558. [Abstract] [Full Text]

				A. L. Cogolludo, F. Perez-Vizcaino, and J. Tamargo Antagonism by Class I Antiarrhythmic Drugs of Levcromakalim-Induced Relaxation in Isolated Rat Aorta J. Pharmacol. Exp. Ther., October 1, 1998; 287(1): 81 - 86. [Abstract] [Full Text]

				K. E. J. Dickinson, C. C. Bryson, R. B. Cohen, L. Rogers, D. W. Green, and K. S. Atwal Nucleotide Regulation and Characteristics of Potassium Channel Opener Binding to Skeletal Muscle Membranes Mol. Pharmacol., September 1, 1997; 52(3): 473 - 481. [Abstract] [Full Text]

				C. Hernandez-Sanchez, T. L. Wood, and D. LeRoith Developmental and Tissue-Specific Sulfonylurea Receptor Gene Expression Endocrinology, February 1, 1997; 138(2): 705 - 711. [Abstract] [Full Text] [PDF]

				H. Kinoshita, Z. S. Katusic, and E. P. Wei Role of Potassium Channels in Relaxations of Isolated Canine Basilar Arteries to Acidosis Stroke, February 1, 1997; 28(2): 433 - 438. [Abstract] [Full Text]

				C. Jiang and G. G. Haddad Modulation of K+ Channels by Intracellular ATP in Human Neocortical Neurons J Neurophysiol, January 1, 1997; 77(1): 93 - 102. [Abstract] [Full Text] [PDF]